RPA43_HUMAN - dbPTM
RPA43_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RPA43_HUMAN
UniProt AC Q3B726
Protein Name DNA-directed RNA polymerase I subunit RPA43
Gene Name TWISTNB
Organism Homo sapiens (Human).
Sequence Length 338
Subcellular Localization Nucleus, nucleolus.
Protein Description DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Component of RNA polymerase I which synthesizes ribosomal RNA precursors. Through its association with RRN3/TIF-IA may be involved in recruitment of Pol I to rDNA promoters..
Protein Sequence MAAGCSEAPRPAAASDGSLVGQAGVLPCLELPTYAAACALVNSRYSCLVAGPHQRHIALSPRYLNRKRTGIREQLDAELLRYSESLLGVPIAYDNIKVVGELGDIYDDQGHIHLNIEADFVIFCPEPGQKLMGIVNKVSSSHIGCLVHGCFNASIPKPEQLSAEQWQTMEINMGDELEFEVFRLDSDAAGVFCIRGKLNITSLQFKRSEVSEEVTENGTEEAAKKPKKKKKKKDPETYEVDSGTTKLADDADDTPMEESALQNTNNANGIWEEEPKKKKKKKKHQEVQDQDPVFQGSDSSGYQSDHKKKKKKRKHSEEAEFTPPLKCSPKRKGKSNFL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
6Phosphorylation--MAAGCSEAPRPAA
--CCCCCCCCCCCCC
35.5620860994
60PhosphorylationHQRHIALSPRYLNRK
CHHEEECCHHHHCCC
9.7923401153
83PhosphorylationDAELLRYSESLLGVP
HHHHHHHHHHHHCCC
17.8027251275
85PhosphorylationELLRYSESLLGVPIA
HHHHHHHHHHCCCEE
23.9721815630
93PhosphorylationLLGVPIAYDNIKVVG
HHCCCEEECCEEEEE
15.3920068231
197AcetylationGVFCIRGKLNITSLQ
EEEEEECEEEECEEE
28.6325953088
211PhosphorylationQFKRSEVSEEVTENG
EEEHHHHCHHHHHCC
24.8025627689
215PhosphorylationSEVSEEVTENGTEEA
HHHCHHHHHCCCHHH
27.3225159151
237PhosphorylationKKKKDPETYEVDSGT
CCCCCCCCEECCCCC
30.3030108239
238PhosphorylationKKKDPETYEVDSGTT
CCCCCCCEECCCCCC
16.5823403867
242PhosphorylationPETYEVDSGTTKLAD
CCCEECCCCCCEECC
43.1225159151
244PhosphorylationTYEVDSGTTKLADDA
CEECCCCCCEECCCC
25.3923403867
245PhosphorylationYEVDSGTTKLADDAD
EECCCCCCEECCCCC
27.8221815630
254PhosphorylationLADDADDTPMEESAL
ECCCCCCCCCHHHHH
25.6925159151
259PhosphorylationDDTPMEESALQNTNN
CCCCCHHHHHHCCCC
22.4530576142
264PhosphorylationEESALQNTNNANGIW
HHHHHHCCCCCCCCC
19.5222210691
297PhosphorylationQDPVFQGSDSSGYQS
CCCCCCCCCCCCCCC
24.4423401153
299PhosphorylationPVFQGSDSSGYQSDH
CCCCCCCCCCCCCHH
27.6223401153
300PhosphorylationVFQGSDSSGYQSDHK
CCCCCCCCCCCCHHH
46.6530266825
302PhosphorylationQGSDSSGYQSDHKKK
CCCCCCCCCCHHHHH
13.5423927012
304PhosphorylationSDSSGYQSDHKKKKK
CCCCCCCCHHHHHHH
32.9529255136
316PhosphorylationKKKKRKHSEEAEFTP
HHHHHCCCCCCCCCC
39.9229255136
322PhosphorylationHSEEAEFTPPLKCSP
CCCCCCCCCCCCCCC
18.5929255136
328PhosphorylationFTPPLKCSPKRKGKS
CCCCCCCCCCCCCCC
31.6929255136
335PhosphorylationSPKRKGKSNFL----
CCCCCCCCCCC----
41.2926074081

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of RPA43_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of RPA43_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RPA43_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RPA2_HUMANPOLR1Bphysical
26186194
RPA1_HUMANPOLR1Aphysical
26186194
RRN3_HUMANRRN3physical
26186194
RRN3_HUMANRRN3physical
28514442
RPAC1_HUMANPOLR1Cphysical
28514442
RPA1_HUMANPOLR1Aphysical
28514442
RPA2_HUMANPOLR1Bphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RPA43_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-316 AND SER-328, ANDMASS SPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60; SER-316 AND SER-328,AND MASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-302, AND MASSSPECTROMETRY.

TOP